Ibitamuno Caleb

Dr. Ibitamuno Caleb


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
ICIbitamuno Caleb
Ibitamuno Caleb
LELuca Erlitz
Luca Erlitz
VTVivien Telek
Vivien Telek
MVMónika Vecsernyés
Mónika Vecsernyés
GSGyorgy Setalo
Gyorgy Setalo
TNTibor Nagy
Tibor Nagy
Cold ischemic injury to the intestine during preservation remains an unresolved issue in transplantation medicine. Autophagy, a cytoplasmic protein degradation pathway, is essential for metabolic adaptation to starvation, hypoxia, and ischemia. It has been implicated in the cold ischemia (CI) of other transplantable organs. This study determines the changes in intestinal autophagy evoked by cold storage and explores the effects of autophagy on ischemic grafts. Cold preservation was simulated by placing the small intestines of Wistar rats in an IGL-1 (Institute George Lopez) solution at 4 °C for varying periods (3, 6, 9, and 12 h). The extent of graft preservation injury (mucosal and cellular injury) and changes in autophagy were measured after each CI time. Subsequently, we determined the differences in apoptosis and preservation injury after activating autophagy with rapamycin or inhibiting it with 3-methyladenine. The results revealed that ischemic injury and autophagy were induced by cold storage. Autophagy peaked at 3 h and subsequently declined. After 12 h of storage, autophagic expression was reduced significantly. Additionally, enhanced intestinal autophagy by rapamycin was associated with less tissue, cellular, and apoptotic damage during and after the 12-h long preservation. After reperfusion, grafts with enhanced autophagy still presented with less injury. Inhibiting autophagy exhibited the opposite trend. These findings demonstrate intestinal autophagy changes in cold preservation. Furthermore, enhanced autophagy was protective against cold ischemia–reperfusion damage of the small bowels.

25 August 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
ICIbitamuno Caleb
Ibitamuno Caleb
BKBenedek Kasza
Benedek Kasza
LELuca Erlitz
Luca Erlitz
DSDávid Semjén
Dávid Semjén
PHPéter Hardi
Péter Hardi
GJGábor Jancsó
Gábor Jancsó
Attenuating the rheological and structural consequences of intestinal ischemia-reperfusion-injury (IRI) is important in transplant proceedings. Preconditioning is an often-proposed remedy. This technique uses physical or pharmacological methods to manipulate key ischemia pathways, such as oxidation, inflammation, and autophagy, prior to ischemia. This study determined the time-dependent effects of Rapamycin preconditioning on small-bowel grafts undergoing cold ischemia perfusion and preservation. Our main parameters were mucosa and cell injury and autophagy. A total of 30 male Wistar rats were divided into 5 groups: sham, preservation-control, and 3 treated groups (Rapamycin administered either 0, 30, or 60 min prior to perfusion). After perfusion, the intestines were placed in chilled IGL-1 solution for 12 h. Thereafter, they were reperfused. Histology and bioanalysis (LDH and lactate) were used to ascertain intestinal injury while immunohistochemistry was used for measuring changes in autophagy markers (Beclin-1, LC3B, and p62 proteins). The results show no significant difference amongst the groups after vascular perfusion. However, intestinal injury findings and autophagy changes demonstrate that administering Rapamycin 30 min or 60 min prior was protective against adverse cold ischemia and reperfusion of the intestinal graft. These findings show that Rapamycin is protective against cold ischemia of the small intestine, especially when administered 30 min before the onset.

21 January 2026 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
ICIbitamuno Caleb
Ibitamuno Caleb
GMGábor Menyhei
Gábor Menyhei
LMLilla Makszin
Lilla Makszin
TNTibor Nagy
Tibor Nagy
DSDorottya Szabó
Dorottya Szabó
GJGábor Jancsó
Gábor Jancsó
Peripheral arterial disease (PAD) is rising globally, impacting healthcare systems. However, in Hungary, and indeed in the Central Eastern European region, which represents an important historical and socioeconomic block, little is known about recent evolution of this disease and the accompanying therapeutic interventions. This study investigated trends over the past decade among patients with PAD in Hungary, focusing on patients with intermittent claudication (IC) and chronic limb threatening ischaemia (CLTI) undergoing revascularisation. Data for patients undergoing revascularisation for IC or CLTI were extracted from the Hungarian Vascular Registry (HUNVASC) from 2011 to 2019 and analysed. Patients were grouped into three time periods: period 1 (2011 - 2013), period 2 (2014 - 2016), period 3 (2017 - 2019) for comparison of characteristics, interventions, and clinical outcomes. In hospital death was the primary outcome of interest. Among 28 587 patients with PAD undergoing revascularisation, IC accounted for 16 908 and CLTI for 11 679 cases. From period 1 to period 3, the proportion of revascularised IC patients increased from 55.2% to 61.6%, while CLTI decreased from 44.8% to 38.4%. There was a general increase in disease burden over time, and patients with CLTI presented with more comorbidities than those with IC. Endovascular procedures were more common in IC. Open interventions declined from 77.6% to 60.0% with a concomitant rise in endovascular and hybrid methods. The in hospital mortality rate remained consistent at 1.4% and did not change considerably with time. Predictors of mortality included CLTI, ischaemic heart disease, chronic kidney disease, chronic pulmonary disease, older age, and open revascularisation. This study showed that patients with CLTI had a higher comorbidity burden and higher rates of open interventions and post-operative complications compared with patients with IC. Although open procedures are declining, it remains the primary method of revascularisation irrespective of the disease cohort. Despite increasing patient comorbidities over time, post-operative mortality rates have not changed significantly.